ORAGENICS, INC. Marketing and Advertising Expense
ORAGENICS, INC. (OGEN) reported Marketing and Advertising Expense of $36.03 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2017-02-27
- ORAGENICS, INC. marketing and advertising expense for fiscal 2016 was $36.03K, a 0.40% increase from fiscal 2015.
- ORAGENICS, INC. marketing and advertising expense for fiscal 2015 was $35.89K, a 41.25% decline from fiscal 2014.
- ORAGENICS, INC. marketing and advertising expense for fiscal 2014 was $61.09K, a 93.18% decline from fiscal 2013.
- ORAGENICS, INC. marketing and advertising expense for fiscal 2013 was $895.08K, a 1721.75% increase from fiscal 2012.
| Period end | Marketing and Advertising Expense 12 month |
|---|---|
| 2016-12-31 | $36.03K 10-K · filed 2017-02-27 |
| 2015-12-31 | $35.89K 10-K · filed 2017-02-27 |
| 2014-12-31 | $61.09K 10-K · filed 2016-03-30 |
| 2013-12-31 | $895.08K 10-K · filed 2015-02-27 |
| 2012-12-31 | $49.13K 10-K · filed 2014-02-28 |
| 2011-12-31 | $735.25K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |